According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.17 Billion. , an increase over its 2023 earnings that were of -ยฃ14.1 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | ยฃ20.33 M | -244.27% |
2023 | -ยฃ14.1 Million | -66.79% |
2022 | -ยฃ42.45 Million | 340.73% |
2021 | -ยฃ9.64 Million | -56.15% |
2020 | -ยฃ21.97 Million | -57.34% |
2019 | -ยฃ51.5 Million | -7.66% |
2018 | -ยฃ55.77 Million | -9.47% |
2017 | -ยฃ61.6 Million | 24.46% |
2016 | -ยฃ49.5 Million | 23.63% |
2015 | -ยฃ40.04 Million | -43.29% |
2014 | -ยฃ70.6 Million | 2.5% |
2013 | -ยฃ68.89 Million | |
2010 | ยฃ29.29 M | -133.97% |
2009 | -ยฃ86.22 Million | -18.49% |
2008 | -ยฃ0.11 Billion | 71.91% |
2007 | -ยฃ61.54 Million | 84.74% |
2006 | -ยฃ33.31 Million | -10.17% |
2005 | -ยฃ37.08 Million | -15.73% |
2004 | -ยฃ44 Million | 39.29% |
2003 | -ยฃ31.59 Million | 10.3% |
2002 | -ยฃ28.64 Million | 48.3% |
2001 | -ยฃ19.32 Million | -2.13% |
2000 | -ยฃ19.74 Million |